Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices

Circulation

Volumn 104, Issue 10, 2001, Pages 1147-1152

  Li, Yun You ^a   Feng, Yiqin ^a   McTiernan, Charles F ^a   Pei, Wei ^a   Moravec, Christine S ^b   Wang, Ping ^a   Rosenblum, Warren ^a   Kormos, Robert L ^a   Feldman, Arthur M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Collagen; Heart failure; Heart assist device; Metalloproteinases; Remodeling

Indexed keywords

COLLAGEN; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; HEART ASSIST DEVICE; HEART DILATATION; HEART FAILURE; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROTEIN CONTENT;

EID: 0035806907     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3501.095215     Document Type: Article

References (32)

1. Left ventricular assist devices and the failing heart: A bridge to recovery, a permanent assist device, or a bridge too far?
2. Surgical therapy for dilated cardiomyopathy
3. Mechanical bridge to myocardial recovery
4. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading
5. Structural and left ventricular histologic changes after implantable LVAD insertion
6. Left ventricular echocardiographic and histologic changes: Impact of chronic unloading by an implantable ventricular assist device
7. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy
8. Regression of cellular hypertrophy after left ventricular assist device support
9. Left ventricular assist deviceinduced reverse ventricular remodeling
10. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure
11. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy
12. Bridge experience with long-term implantable left ventricular assist devices: Are they an alternative to transplantation?
13. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure
14. Ventricular assistance for recovery of cardiac failure
15. Role of extracellular matrix in dilated cardiomyopathy
16. The matrix metalloproteinase family
17. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy
18. Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts
19. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy
20. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart
21. Activation of matrix metalloproteinases in the failing human heart: Breaking the tie that binds
22. Myocardial matrix metalloproteinase activity and abundance with congestive heart failure
23. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: Relation to ventricular and myocyte function
24. Expression of metalloproteases by cardiac myocytes and fibroblasts in vitro
25. Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells
26. Preparation and characterization of the different types of collagen
27. Determination of hydroxyproline
28. Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats
29. Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction
30. Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase
31. Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit
32. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support